Point72 Asset Management, L.P. 13D and 13G filings for Reata Pharmaceuticals, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2023-02-14 4:12 pm Sale | 2022-12-31 | 13G | Reata Pharmaceuticals, Inc. RETA | Point72 Asset Management, L.P. | 10,673 0.100% | -1,653,394 (-99.36%) | Filing |
| 2022-09-22 4:40 pm Purchase | 2022-09-21 | 13G | Reata Pharmaceuticals, Inc. RETA | Point72 Asset Management, L.P. | 1,664,067 5.300% | 1,664,067 (New Position) | Filing |